PATENT CLAIM ANALYSIS

Application Number: 15906268
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "233200"]

Abstract:
The present invention is directed to novel compounds of formula I and their use as therapeutic compounds.

Claim (Index 26):
The pharmaceutical composition according to  claim 25  comprising a compound selected from formulae Il-1, Il-2, Il-3, Il-4, Il-5, Il-6, Il-7, Il-8, Il\u2032-1, Il\u2032-2, Il\u2032-3, Il\u2032-4, Il\u2032-5, Il\u2032-6, Il\u2032-7, Il\u2032- 8 or a pharmaceutically acceptable salt or solvate thereof and at least one pharmaceutically acceptable carrier, diluent, excipient and/or adjuvant, wherein: a depicts the bond linking R 1  to the piperazine moiety; and R 1 , X 1  and X 2  are as defined in claim  2 ; and R 4 , R 4\u2032 , R 5 , R 5\u2032 , R 6 , M 1  and M 2  are as defined in claim  4 ; and R 12\u2032 , R 13 , R 14 , R 14\u2032 , R 15 , R 18 , R 19 , R 19\u2032 , R 20 , R 21 , R 21\u2032 , R 22 , R 22\u2032 , R 23 , R 24 , R 24\u2032 , R 25 , R 25\u2032 , R 26 , R 27 , R 27\u2032 , R 28 , R 28\u2032 , R 29 , R 29\u2032 , R 30 , R 30\u2032 , R 31 , R 31\u2032 , R 32 , R 32\u2032 , R 33 , R 34 , R 35 , X 3 , X 5 ; X 6 ; and the two bonds represented by the dotted lines are as defined in claim  7 .

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14349595', '14799208', '13627091', '15259922', '15205304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8178377071947514
- 35 USC 102 Novelty (BERT): 0.6088104517189689
- Combined Prediction Score: 0.7969349816471731
- Mean Citation Score: 548.391766
- Max Citation Score: 607.86743
- Similarity Product: 455.04695312412736

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test